Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2016-0362
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM TRIRIGA Application Platform 3.3 before 3.3.2.6, 3.4 before 3.4.2.4, and 3.5 before 3.5.0.2 allows remote authenticated users to conduct server-side request forgery (SSRF) attacks, and trigger network traffic to arbitrary intranet or Internet hosts, via a crafted proxy request to a web service.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM TRIRIGA Application Platform 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM TRIRIGA Application是美国IBM公司的一套用于管理设备生命周期的系统。 IBM TRIRIGA Application Platform中存在安全漏洞。远程攻击者可通过发送特制的代理请求利用该漏洞使实施服务器端请求伪造攻击,向其他的内部/外部网络资源转发HTTP请求。以下版本受到影响:IBM TRIRIGA Application Platform 3.5版本,3.4版本,3.3版本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2016-0362
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2016-0362
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2016-0362

No comments yet


Leave a comment